Bicycle Therapeutics (BCYC) Total Non-Current Liabilities (2018 - 2026)

Bicycle Therapeutics has reported Total Non-Current Liabilities for 9 years, with the latest figure at $97.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 31.83% year-over-year to $97.1 million; the trailing twelve-month figure through Mar 2026 stood at $97.1 million (down 31.83% YoY), and the FY2025 full-year result was $106.6 million, down 34.48% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $97.1 million, down from $106.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $229.7 million in Q2 2023, with the low at $97.1 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $159.2 million across 5 years, with a median of $159.8 million in 2024.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 75.6% — and 2025, when it sank 34.48%.
• Bicycle Therapeutics' Total Non-Current Liabilities stood at $136.0 million in 2022, then jumped by 61.65% to $219.8 million in 2023, then declined by 26.0% to $162.7 million in 2024, then sank by 34.48% to $106.6 million in 2025, then declined by 8.9% to $97.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $97.1 million (Q1 2026), $106.6 million (Q4 2025), and $144.4 million (Q3 2025), per Business Quant data.